241
Views
7
CrossRef citations to date
0
Altmetric
Research Articles

Novel ethylcellulose-coated pellets for controlled release of metoprolol succinate without lag phase: characterization, optimization and in vivo evaluation

, , , , , , & show all
Pages 1120-1129 | Received 28 Mar 2014, Accepted 02 Jun 2014, Published online: 01 Jul 2014

References

  • Bose S, Bogner RH. Solventless pharmaceutical coating processes: a review. Pharm Dev Technol 2007;12:115–31
  • Ho L, Cuppok Y, Muschert S, et al. Effects of film coating thickness and drug layer uniformity on vitro drug release from sustained-release coated pellets: a case study using terahertz pulsed imaging. Int J Pharm 2009;382:151–9
  • Siepmann F, Hoffmann A, Leclercq B, et al. How to adjust desired drug release patterns from ethylcellulose-coated dosage forms. J Control Release 2007;119:182–9
  • Marucci M, Andersson H, Hjärtstam J, et al. New insights on how to adjust the release profile from coated pellets by varying the molecular weight of ethyl cellulose in the coating film. Int J Pharm 2013;458:218–23
  • Ozturk AG, Ozturk SS, Palsson BO, et al. Mechanism of release from pellets coated with an ethylcellulose-based film. J Control Release 1990;14:203–13
  • Ragnarsson G, Sandberg A, Johansson MO, et al. In vitro release characteristics of a membrane-coated pellet formulation—influence of drug solubility and particle size. Int J Pharm 1992;79:223–32
  • Marucci M, Ragnarsson G, Nyman U, Axelsson A. Mechanistic model for drug release during the lag phase from pellets coated with a semi-permeable membrane. J Control Release 2008;127:31–40
  • Marucci M, Ragnarsson G, von Corswant C, et al. Polymer leaching from film coating: effects on the coating transport properties. Int J Pharm 2011;411:43–8
  • Haddish-Berhane N, Jeong SH, Haghighi K, Park K. Modeling film-coat non-uniformity in polymer coated pellets: a stochastic approach. Int J Pharm 2006;323:64–71
  • Ensslin S, Moll KP, Paulus K, Mäder K. New insight into modified release pellets-Internal structure and drug release mechanism. J Control Release 2008;128:149–56
  • Kaunisto E, Marucci M, Borgguist P, Axelsson A. Mechanistic modeling of drug release from polymer-coated and swelling and dissolving polymer matrix systems. Int J Pharm 2011;418:54–77
  • Appel LE, Friesen DT, Herbig SM, Thombre AG. Controlled release dosage forms combining immediate release and sustained release of low-solubility drug. US Patent 2008/0299188 A1; 2008
  • Marucci M, Hjartstam J, Ragnarsson G, et al. Coated formulation: new insight into the release mechanism and changes in the film properties with a novel release cell. J Control Release 2009;139:206–12
  • Marucci M, Ragnarsson G, Axelsson A. Evaluation of osmotic effects on coated pellets using a mechanistic model. Int J Pharm 2007;336:67–74
  • Lin WJ, Shiue GR. Elucidation of two water leachable polymers impact on microporous membrane performance and drug permeation. J Memb Sci 2011;373:189–95
  • Tuntikulwattana S, Mitrevej A, Kerdcharoen T, et al. Development and optimization of micro/nanoporous osmotic pump tablets. AAPS PharmSciTech 2010;11:924–35
  • Bodmeier R, Paeratakul O. Constant potassium chloride release from microporous membrane-coated tablets prepared with aqueous colloidal polymer dispersions. Pharm Res 1991;8:355–9
  • Kim JE, Kim SR, Lee SH, et al. The effect of pore formers on the controlled release of cefadroxil from a polyurethane matrix. Int J Pharm 2000;201:29–36
  • Heckötter UM, Larsson A, Sriamornsak P, et al. Effect of annealing time and addition of lactose on release of a model substance from Eudragit® RS coated pellets produced by a fluidized bed coater. Chem Eng Res Des 2011;89:697–705
  • Mishra M, Mishra B. Design and evaluation of microporous membrane coated matrix tablets for a highly water soluble drug. Chem Pharm Bull (Tokyo) 2010;58:995–1000
  • Zhang X, Wang Y, Wang J, et al. Effect of pore former on the properties of casted film prepared from blends of Eudragit NE 30 D and Eudragit L 30 D-55. Chem Pharm Bull (Tokyo) 2007;55:1261–3
  • Garg A, Gupta M, Bhargava HN. Effect of formulation parameters on the release characteristics of propranolol from asymmetric membrane coated tablets. Eur J Pharm Biopharm 2007;67:725–31
  • Wakode R, Bhanushali R, Bajaj A. Development and evaluation of push-pull based osmotic delivery system for pramipexole. PDA J Pharm Sci Technol 2008;62:22–31
  • Gunder W, Lippold BH, Lippold BC. Release of drugs from ethyl cellulose microcapsules (diffusion pellets) with pore formers and pore fusion. Eur J Pharm Sci 1995;3:203–14
  • Verma RK, Kaushal AM, Garg S. Development and evaluation of extended release formulations of isosorbide mononitrate based on osmotic technology. Int J Pharm 2003;263:9–24
  • Marucci M, Ragnarsson G, Nilsson B, Axelsson A. Osmotic pumping release from ethyl–hydroxypropyl–cellulose-coated pellets: a new mechanistic model. J Control Release 2010;142:53–60
  • Andersson H, Hjärtstam J, Stading M, et al. Effects of molecular weight on permeability and microstructure of mixed ethyl-hydroxypropyl-cellulose films. Eur J Pharm Sci 2013;48:240–8
  • Lecomte F, Siepmann J, Walther M, et al. pH-sensitive polymer blends used as coating materials to control drug release from spherical beads: elucidation of the underlying mass transport mechanisms. Pharm Res 2005;22:1129–41
  • Lin WJ, Shiue GR. Elucidation of two water leachable polymers impact on microporous membrane performance and drug permeation. J Memb Sci 2011;373:189–95
  • Siepmann F, Siepmann J, Walther M, et al. Polymer blends for controlled release coatings. J Control Release 2008;125:1–15
  • Ravishankar H, Patil P, Samel A, et al. Modulated release metoprolol succinate formulation based on ionic interactions: in vivo proof of concept. J Control Release 2006;111:65–72
  • Kendall MJ, Maxwell SR, Sandberg A, Westergren G. Controlled release metoprolol, Clinical pharmacokinetic and therapeutic implications. Clin Pharamcokinet 1991;5:319–30
  • Nazzal S, Nutan M, Palamakula A, et al. Optimization of a self-nanoemulsified tablet dosage form of ubiquinone using response surface methodology: effect of formulation ingredients. Int J Pharm 2002;240:103–14
  • Huang YB, Tsai YH, Lee SH, et al. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology. Int J Pharm 2005;289:87–95
  • Kállai N, Luhn O, Dredán J, et al. Evaluation of drug release from coated pellets based on isomalt, sugar, and microcrystalline cellulose inert cores. AAPS PharmSciTech 2010;11:383–91
  • Ochoa L, Igartua M, Hernández RM, et al. Novel extended-release formulation of lovastatin by one-step melt granulation: in vitro and in vivo evaluation. Eur J Pharm Biopharm 2011;77:306–12
  • Zhao N, Ahmed Z, Mobin T, et al. Tablet splitting: product quality assessment of motoprolol succinate extended release tablets. Int J Pharm 2010;401:25–31
  • Ahmad H, Khalifeh I, Alkhalidi B, et al. Application of active layering and coating techniques in the development of a multiparticulate, controlled release dosage form of a high-dose, highly soluble drug. Pharm Dev Technol 2014;19:556–64
  • Fielden KE, Newton JM, Rowe RC. The effect of lactose particle sizeon the extrusion properties of microcrystalline cellulose-lactose mixture. J Pharm Pharmacol 1989;41:217–21
  • Wan LSC, Lai WF. The influence of antitack additives on drug release from film-coated granules. Int J Pharm 1993;94:39–47
  • Marucci M, Arnehed J, Jarke A, et al. Effect of the manufacturing conditions on the structure and permeability of polymer films intended for coating undergoing phase separation. Eur J Pharm Biopharm 2013;83:301–6
  • Peppas NA. Mathematical models for controlled release kinetics. In: Langer R, Wise D, eds. Medical applications of controlled release: applications and evaluations, vol. II. Boca Raton (FL): CRS Press; 1995:169–87
  • Gao C, Huang J, Jiao Y, et al. In vitro release and in vivo absorption in beagle dogs of meloxicam from Eudragit® FS 30 D-coated pellets. Int J Pharm 2006;322:104–12

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.